Back | Next |
home / stock / abbv / abbv message board
Subject | By | Source | When |
---|---|---|---|
$ABBV 1Q22 CC transcript: | DewDiligence | investorshub | 05/01/2022 5:58:44 PM |
Didn't expect that. Bailed and wiped out most | retired early | investorshub | 04/29/2022 2:46:17 PM |
$ABBV 1Q22 results: | DewDiligence | investorshub | 04/29/2022 12:29:28 PM |
Or perhaps we are done correcting? :) | retired early | investorshub | 04/27/2022 7:29:46 PM |
Thanks DewDilligence, you are most likely right about | Just the facts maam | investorshub | 04/25/2022 11:18:19 AM |
Androgel is now available as a generic, so | DewDiligence | investorshub | 04/24/2022 3:56:36 PM |
Question for the board, is AbbVie interested in | Just the facts maam | investorshub | 04/24/2022 11:05:00 AM |
whytestocks: $ABBV News Article - LAWSUITS FILED AGAINST GATO, ABBV and AUPH - Jakubowitz Law Pursue | whytestocks | investorshangout | 04/21/2022 6:50:53 PM |
Up too fast perhaps. Maybe a new 120 base? | retired early | investorshub | 04/17/2022 3:58:23 PM |
$ABBV Chart | conix | investorshub | 04/17/2022 12:46:09 PM |
whytestocks: $ABBV News Article - Best Biotech Stocks To Buy Now? 5 To Know | whytestocks | investorshangout | 04/14/2022 5:55:49 PM |
whytestocks: $ABBV News Article - AbbVie to Host First-Quarter 2022 Earnings Conference Call | whytestocks | investorshangout | 04/14/2022 4:45:50 PM |
$ABBVs #2 executive, Mike Severino, is leaving to | DewDiligence | investorshub | 04/13/2022 4:27:08 PM |
Wow a $13 mil buy @ end | retired early | investorshub | 04/03/2022 2:42:52 PM |
FDA approves Rinvoq for second-line ulcerative colitis: | DewDiligence | investorshub | 03/17/2022 12:40:47 AM |
Recent investor. Looks like a safer long term | retired early | investorshub | 03/15/2022 3:19:48 PM |
$ABBV reports positive Qulipta phase-3 in prevention of | DewDiligence | investorshub | 03/10/2022 2:34:31 PM |
Alvotech settles Humira-US-patent litigation with $ABBV: | DewDiligence | investorshub | 03/09/2022 12:33:11 AM |
Skyrizi PDUFA date for Crohns disease extended three | DewDiligence | investorshub | 03/01/2022 12:32:11 AM |
Rinvoq succeeds in second Phase-3 in Crohns: | DewDiligence | investorshub | 02/24/2022 4:48:04 PM |
News, Short Squeeze, Breakout and More Instantly...
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis PR Newswire The positive opinion is based on results from two pivotal Phase 3 trials, INSPIRE and COMMAND, that evaluated ...
2024-05-30 05:45:00 ET Sometimes, misperceptions can work in investors' favor. When others think the outlook for a stock isn't so great, you can win big if that view is overly pessimistic. Several stocks that pay fantastic dividends are in that category. Here are three dividend stocks t...
NEW YORK, NY / ACCESSWIRE / May 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Cerevel Therapeutics Holdings, Inc. ("Cerevel") (NASDAQ:CERE) and AbbVie, Inc. ("AbbVie") (NYSE:ABBV). Investors who purchased Cerevel and continue to holdto the present are enco...